FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials

Nicole Verdun at 2023 ASGCT Policy Summit
Nicole Verdun (left) discussed accelerated approval and other cell and gene therapy issues during the ASGCT Policy Summit. • Source: Screenshot of conference livestream
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies